Citation: Jb. Alavi et al., DETECTION OF UNSUSPECTED RECURRENT LYMPHOMA WITH FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHIC IMAGING AFTER INDUCTION CHEMOTHERAPY - A CASE-STUDY, American journal of clinical oncology, 21(2), 1998, pp. 126-128
Citation: F. Benard et al., PET FDG IMAGING IN THE RESTAGING OF METASTATIC BREAST-CANCER BEFORE HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT, The Journal of nuclear medicine, 38(5), 1997, pp. 252-252
Authors:
ECK SL
ALAVI JB
ALAVI A
DAVIS A
HACKNEY D
JUDY K
MOLLMAN J
PHILLIPS PC
WHEELDON EB
WILSON JM
Citation: Sl. Eck et al., CLINICAL PROTOCOL - TREATMENT OF ADVANCED CNS MALIGNANCIES WITH THE RECOMBINANT ADENOVIRUS-H5.010RSVTK - A PHASE-I TRIAL, Human gene therapy, 7(12), 1996, pp. 1465-1482
Citation: Ca. Buchpiguel et al., PET VERSUS SPECT IN DISTINGUISHING RADIATION NECROSIS FROM TUMOR RECURRENCE IN THE BRAIN, The Journal of nuclear medicine, 36(1), 1995, pp. 159-164
Authors:
BUCHPIGUEL CA
ALAVI JB
ALAVI A
SMITH RJ
MEEHAN D
RIGGIN SL
Citation: Ca. Buchpiguel et al., COMPARISON OF PET-FDG AND SPECT TL-201 IN DISTINGUISHING RADIATION NECROSIS FROM TUMOR RECURRENCE IN THE BRAIN, The Journal of nuclear medicine, 35(5), 1994, pp. 160000222-160000223
Authors:
TSE KKM
BUCHPIGUEL CA
ALAVI JB
ALAVI A
SMITH RJ
RIGGIN SL
MEEHAN D
Citation: Kkm. Tse et al., DETECTION AND SEMIQUANTITATIVE MEASUREMENT OF LUNG-CANCER METABOLIC-ACTIVITY BY WHOLE-BODY PET-FDG IMAGING, The Journal of nuclear medicine, 35(5), 1994, pp. 160000226-160000226